EGFR tyrosine kinase inhibitors in squamous cell lung cancer

Lancet Oncol. 2015 Aug;16(8):872-3. doi: 10.1016/S1470-2045(15)00126-6. Epub 2015 Jul 5.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Carcinoma, Squamous Cell / drug therapy*
  • Female
  • Humans
  • Lung Neoplasms / drug therapy*
  • Male
  • Protein Kinase Inhibitors / therapeutic use*
  • Quinazolines / therapeutic use*

Substances

  • Antineoplastic Agents
  • Protein Kinase Inhibitors
  • Quinazolines